U.S. Pharma Stock News

NYSE:BLDR
NYSE:BLDRBuilding

Builders FirstSource Earnings Miss Raises Questions On Valuation And Outlook

Builders FirstSource (NYSE:BLDR) recently reported an earnings miss alongside weaker operating metrics. The company highlighted ongoing pressure on revenue and EPS, reflecting sector wide headwinds in building materials. These operational challenges come as the stock trades around $95.99 and investors reassess the company’s growth and profitability profile. For investors watching NYSE:BLDR, the latest results come after a tough stretch in the share price, with the stock down 6.5% over the...
NasdaqGS:ROOT
NasdaqGS:ROOTInsurance

Does Root’s (ROOT) Strong 2025 Results but Softer Q4 Profit Reframe Its Profitability Story?

Root, Inc. previously reported fourth-quarter 2025 revenue of US$397 million, up from US$326.7 million a year earlier, with net income of US$5.1 million compared with US$20.9 million. For 2025 overall, Root lifted revenue to US$1.52 billion and increased net income to US$38.3 million, but its fourth-quarter profit was lower than the prior year despite higher sales. Next, we’ll examine how Root’s higher full-year revenue and earnings, alongside weaker quarterly profit, may influence its...
NYSE:INSW
NYSE:INSWOil and Gas

International Seaways Supplemental Dividend Puts Cash Returns And Valuation In Focus

International Seaways (NYSE:INSW) has announced a major supplemental dividend to be paid alongside its regular quarterly dividend. The Board of Directors approved the additional payout, signaling a significant return of capital to shareholders. The decision reflects management's view of the company’s current financial position and cash resources. International Seaways focuses on crude and product tanker shipping, a segment that tends to be closely linked to global energy trade and fleet...
NasdaqCM:HYMC
NasdaqCM:HYMCMetals and Mining

Hycroft Mining Reset Puts Larger Resources And Funding Needs In Focus

Hycroft Mining Holding (NasdaqCM:HYMC) reports a 55% increase in its gold and silver mineral resource base. The company eliminates all debt and shifts its focus from production to exploration and development. Hycroft launches its largest exploration drill program to date. The stock is added to the MSCI Small Cap Index, increasing its visibility with institutional investors. Hycroft Mining Holding, trading at $47.665, has gone through a major reset that is drawing fresh attention from the...
NYSE:MLI
NYSE:MLIMachinery

How Investors Are Reacting To Mueller Industries (MLI) 40% Quarterly Dividend Increase

Mueller Industries’ Board of Directors has increased its regular quarterly cash dividend to US$0.35 per share, payable on March 27, 2026, to shareholders of record as of March 13, 2026, marking a 40% rise over the 2025 quarterly dividend. This sizeable dividend boost highlights management’s willingness to return more cash to shareholders, a move that can be particularly meaningful for income-oriented investors. We’ll now examine how this 40% dividend increase shapes Mueller Industries’...
NYSE:YETI
NYSE:YETILeisure

New YETI CFO From Home Depot May Reshape Growth And Capital Choices

YETI Holdings (NYSE:YETI) has appointed Scott Bomar as its new Chief Financial Officer. Bomar joins the company from The Home Depot, bringing financial and operational leadership experience. He succeeds long serving CFO Mike McMullen, marking a key change in YETI's executive team. YETI Holdings, known for its premium coolers, drinkware and outdoor gear, sits at the intersection of consumer brands and the broader outdoor recreation and lifestyle market. For investors watching branded...
NasdaqGM:EXPI
NasdaqGM:EXPIReal Estate

Assessing eXp World Holdings (EXPI) Valuation After Recent Share Price Weakness

Why eXp World Holdings (EXPI) is on investors’ radar Recent trading in eXp World Holdings (EXPI) has drawn attention after a stretch of weak returns, including declines over the past month, past 3 months and year, prompting closer scrutiny of the stock. See our latest analysis for eXp World Holdings. At a share price of $6.84, eXp World Holdings has seen a 23.23% 1 month share price decline and a 30.79% 1 year total shareholder return decline. This suggests momentum has been fading as...
NasdaqGS:OMCL
NasdaqGS:OMCLMedical Equipment

Omnicell Leans Into Healthcare IT As ANiGENT Deal Reshapes Growth Story

Omnicell, ticker NasdaqGS:OMCL, is shifting its focus toward a software and services led model. The company recently acquired ANiGENT to deepen its capabilities in drug diversion detection within healthcare settings. This move marks a meaningful step in Omnicell's transition from a hardware vendor to a Healthcare IT company. Omnicell's pivot comes after a mixed share price record, with the stock at $41.53 and a value score of 4. The shares show a 9.8% gain over the past year, while longer...
NYSE:NE
NYSE:NEEnergy Services

Assessing Noble (NE) Valuation After Strong Recent Share Price Momentum

Why Noble Is On Investors' Radar Noble (NE), an offshore drilling contractor headquartered in Houston, has drawn attention after a strong stock move over the past month. This has prompted investors to recheck how its current valuation lines up with its fundamentals. See our latest analysis for Noble. Beyond the recent move, Noble’s 30 day share price return of 27.28% and year to date share price return of 58% sit alongside a 1 year total shareholder return of 116.6%. This indicates strong...
NasdaqGS:CALM
NasdaqGS:CALMFood

Cal Maine Expands Indiana Egg Operations As Valuation Gap Draws Attention

Cal-Maine Foods (NasdaqGS:CALM) has completed the acquisition of Creighton Brothers LLC and Crystal Lake LLC. The deal expands Cal-Maine's shell egg, egg products, and prepared foods operations into Indiana. The transaction adds production capacity and internal supply chain resources across conventional and specialty egg categories. For you as an investor, this move adds another piece to the Cal-Maine story as the company increases its presence across the U.S. egg market. NasdaqGS:CALM is a...
NYSE:EPRT
NYSE:EPRTREITs

Is Essential Properties Realty Trust (EPRT) Still Attractive After Recent Share Price Gains

If you are wondering whether Essential Properties Realty Trust is reasonably priced or starting to look expensive, you are not alone. The stock last closed at US$34.57, with returns of 3.4% over 7 days, 14.8% over 30 days, 15.0% year to date and 12.0% over the past year, which naturally raises questions about what is already reflected in the price. Recent attention on Essential Properties Realty Trust has largely focused on its role as a net lease REIT and how that business model fits into...
NYSE:STVN
NYSE:STVNLife Sciences

Stevanato Group (NYSE:STVN) Margin Improvement To 12% Tests Bullish Earnings Narratives

Stevanato Group FY 2025 Earnings Snapshot Stevanato Group (NYSE:STVN) has put another solid quarter on the board for FY 2025, with Q3 revenue of €303.2 million and basic EPS of €0.13, alongside trailing twelve month EPS of €0.52 on €1.17 billion of revenue, capped by 22.6% earnings growth over the past year. The company has seen revenue move from €259.6 million in Q2 2024 to €303.2 million in Q3 2025, while quarterly EPS has ranged between €0.08 and €0.18 over that period, setting up a...
NasdaqGM:STAA
NasdaqGM:STAAMedical Equipment

STAAR Surgical (STAA) Posts US$80.4 Million Annual Loss Testing Turnaround Narratives

STAAR Surgical FY 2025 earnings snapshot STAAR Surgical (STAA) has wrapped up FY 2025 with Q4 revenue of US$57.8 million and a basic EPS loss of US$0.37, keeping the focus firmly on the path back to profitability. The company has seen quarterly revenue range from US$42.6 million to US$94.7 million since the start of 2024, while basic EPS has swung between a loss of US$1.10 and a profit of US$0.20. This sets up a mixed picture on margins that investors may view as an ongoing turnaround story...
NasdaqCM:SRTA
NasdaqCM:SRTAHealthcare

Strata Critical Medical Q4 Loss Underscores Ongoing Profitability Gap Versus Bullish Narratives

Strata Critical Medical (SRTA) has reported its FY 2025 numbers, with Q4 revenue at US$66.8 million and a basic EPS loss of US$0.06. Trailing twelve month revenue came in at US$197.1 million with a full year basic EPS loss of US$0.24. Over recent quarters, the company has reported revenue in a range from US$36.1 million to US$66.8 million, while quarterly basic EPS losses have moved between US$0.04 and US$0.12. This keeps the focus on how efficiently it is converting sales into earnings. With...
NasdaqCM:UFPT
NasdaqCM:UFPTMedical Equipment

Does UFP Technologies' (UFPT) Expanded Intuitive Deal Reframe Its Medical Automation Investment Narrative?

In late February 2026, UFP Technologies, Inc. extended and expanded its manufacturing supply agreement with Intuitive Surgical through December 31, 2029, while also reporting higher fourth-quarter and full-year 2025 sales and earnings compared with the prior year. This combination of a longer-term, higher-volume partnership with a key customer and recent earnings growth adds further visibility to UFP Technologies’ medical device exposure and contracted revenue base. Next, we’ll examine how...
NasdaqGS:EYE
NasdaqGS:EYESpecialty Retail

Same Store Sales Strength Tests Profitability Concerns At National Vision Holdings (EYE)

National Vision Holdings (EYE) has put up a mixed FY 2025 scorecard so far, with Q3 revenue at US$487.3 million, basic EPS of US$0.04 and same store sales growth of 7.7%, set against a trailing twelve month loss of US$3.2 million and basic EPS of roughly US$0.04 loss. Over recent quarters the company has seen revenue range from US$451.7 million in Q2 2024 to US$510.3 million in Q1 2025. Basic EPS has moved from a Q4 2024 loss of US$0.37 per share to a Q1 2025 profit of US$0.18 per share and...
NYSE:ACEL
NYSE:ACELHospitality

Accel Entertainment (ACEL) Margin Improvement Challenges Bears Focused On Concentration Risks

Accel Entertainment (ACEL) has wrapped up FY 2025 with fourth quarter revenue of US$341.4 million and EPS of US$0.19, capping a year in which trailing twelve month revenue reached US$1.3 billion and EPS came in at US$0.61. The company has seen quarterly revenue move from US$302.2 million in Q3 2024 to US$341.4 million in Q4 2025, while quarterly EPS stepped up from US$0.06 to US$0.19 over the same stretch, setting the backdrop for investors focused on earnings growth and profit consistency...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

CrowdStrike (CRWD) First Profitable Quarter Challenges Trailing Loss Narrative

CrowdStrike Holdings (CRWD) FY 2026 results in focus CrowdStrike Holdings (CRWD) has capped FY 2026 with fourth quarter revenue of about US$1.3 billion and basic EPS of US$0.15, alongside trailing twelve month revenue of roughly US$4.8 billion and a trailing basic EPS loss of US$0.65. The company has seen quarterly revenue move from US$1.06 billion in Q4 FY 2025 to US$1.31 billion in Q4 FY 2026, while basic EPS shifted from a loss of US$0.37 to a profit of US$0.15 over the same periods. For...
NasdaqGS:CCOI
NasdaqGS:CCOITelecom

A Look At Cogent Communications Holdings (CCOI) Valuation After Recent Share Price Volatility

Event context and recent stock moves Cogent Communications Holdings (CCOI) has been drawing attention after recent share price swings, with the stock showing a 6.7% move over the past day and a 24.9% change over the past week. Those short term moves sit alongside a month decline of 6.6% and a past 3 months gain of 23.1%, while the 1 year total return stands at a 64.9% decline, giving investors mixed signals to assess. See our latest analysis for Cogent Communications Holdings. At a share...
NasdaqGM:ACNT
NasdaqGM:ACNTChemicals

Ascent Industries ACNT Persistent Losses Challenge Bullish Narratives Despite Premium Price To Sales Multiple

Ascent Industries FY 2025 earnings snapshot Ascent Industries (ACNT) closed out FY 2025 with Q4 revenue of US$18.8 million and a basic EPS loss of US$0.11, while trailing 12 month EPS stood at a loss of US$0.58 on revenue of US$74.9 million. The company has seen quarterly revenue move from US$40.7 million in Q4 FY 2024 to US$18.8 million in Q4 FY 2025, alongside basic EPS shifting from a profit of US$0.01 to a loss of US$0.11. This keeps the focus firmly on how efficiently each dollar of...
OTCPK:FTCO
OTCPK:FTCOMetals and Mining

Fortitude Gold (OTCPK:FTCO) Q3 Profit Challenges Bearish Loss Narratives

Fortitude Gold (FTCO) has reported its FY 2025 third quarter with revenue of US$4.7 million, basic EPS of US$0.0096 and net income of US$0.2 million. Trailing 12 month figures sit at US$25.4 million in revenue and a net loss of US$0.5 million with basic EPS at US$0.021. Over recent quarters in FY 2025, revenue has moved from US$6.5 million in Q1 to US$4.9 million in Q2, and EPS has shifted from US$0.0517 in Q1 to US$0.0350 in Q2. Together, these figures give a clearer sense of how the income...
NasdaqGS:WEYS
NasdaqGS:WEYSRetail Distributors

Weyco Group TTM Margin Decline Reinforces Bearish Profitability Narratives

Weyco Group (WEYS) has wrapped up FY 2025 with fourth quarter revenue of US$76.8 million and basic EPS of US$0.92, alongside net income excluding extra items of US$8.7 million, setting the tone for how the full year is being judged. Over recent quarters the company has seen revenue move from US$80.5 million and EPS of US$1.05 in Q4 2024 to US$73.1 million and US$0.70 in Q3 2025, before landing at the latest levels. This gives investors a clear view of how the top line and EPS have tracked...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

Is It Too Late To Consider EyePoint (EYPT) After A 1‑Year Surge And DCF Upside?

If you are wondering whether EyePoint's share price still reflects fair value after a strong run, you are not alone. This article is here to help you size that up clearly. The stock last closed at US$18.00, with returns of 1.4% over 7 days, 35.4% over 30 days, 3.0% year to date, 173.6% over 1 year, a gain of around 7x over 3 years, and 72.2% over 5 years. Recent news coverage around EyePoint has focused on its position in ophthalmology and its pipeline, which has kept investor attention on...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Is Fortrea Holdings (FTRE) Now An Opportunity After A 38.4% Share Price Slide?

If you are wondering whether Fortrea Holdings' current share price matches its underlying worth, you are not alone. This article will walk through what the numbers actually say about value. Over the past month the stock has seen a sharp 38.4% decline, following a relatively small 0.4% gain over the last 7 days and a 4.7% decline over the past year. This naturally raises questions about whether risk perceptions or return expectations have shifted. Recent news coverage has largely focused on...